The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial of TG01/GM-CSF and gemcitabine as adjuvant therapy for treating patients with resected RAS-mutant adenocarcinoma of the pancreas.
 
Daniel H. Palmer
Honoraria - Bayer; Bristol-Myers Squibb; Celgene; Nucana
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Nucana
Research Funding - Bayer; Nucana
 
Svein Dueland
No Relationships to Disclose
 
Juan W. Valle
Consulting or Advisory Role - Agios; AstraZeneca; Baxalta; Delcath Systems; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Pfizer
Speakers' Bureau - Celgene; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis
 
Anne-Kirsti Aksnes
Employment - Targovax
Stock and Other Ownership Interests - Targovax